Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Prog Neurobiol. 2022 Jul 14;217:102316. doi: 10.1016/j.pneurobio.2022.102316

Table 2.

Expression of ELAVL4 and ELAVL4 targets after ELAVL4 manipulation

ELAVL4 knock out ELAVL4 overexpression ELAVL4 rescue in knock out

RNAseq Protein RNAseq RNAseq Protein
fAD corrected fAD fAD corrected fAD fAD corrected fAD fAD corrected fAD
Gene FC FDR-P FC FDR-P FC FDR-P FC FDR-P FC FDR-P FC FDR-P FC FDR-P FC FDR-P
ELAVL4/HuD −4,47 2,86E-37 3,24 8,13E-34 N.A. N.D. 2,86 8,49E-33 2,62 2,25E-31 15,14 3,11E-48 9,40 1,13E-45 1,635 1,21E-11
CAMK2A 1,92 8,26E-12 1,10 2,42E-01 N.A. N.D. −1,26 5,71E-02 −1,29 3,13E-02 −1,96 1,30E-10 −1,53 1,43E-05 N.A N.D.
BDNF 1,17 4,83E-03 −1,19 1,55E-01 N.A. N.D. −1,13 1,89E-01 −1,04 7,80E-01 −1,18 1,13E-02 −1,15 3,58E-02 N.A N.D.
GAP43 −1,07 4,00E-03 1,11 1,19E-04 1,21 1,05E-03 1,09 1,17E-02 1,12 1,07E-03 1,14 9,46E-06 1,07 3,02E-02 −1,19 1,89E-03
APP 1,16 7,03E-13 −1,06 4,32E-04 N.A. N.D. 1,02 4,51E-01 −1,10 8,38E-02 −1,05 4,18E-03 −1,03 1,16E-01 N.A N.D.
BACE1 1,13 6,71E-04 1,03 4,78E-01 N.A. N.D. 1,08 1,26E-01 −1,05 8,54E-01 1,01 8,06E-01 1,02 6,84E-01 N.A N.D.
ADAM10 −1,10 1,69E-03 −1,02 6,53E-01 N.A. N.D. −1,10 2,73E-02 −1,04 4,74E-01 −1,22 5,78E-07 −1,12 3,48E-03 N.A N.D.
NEP −3,21 7,98E-08 −1,23 3,39E-01 N.A. N.D. −1,35 2,77E-01 −1,14 7,80E-01 −1,07 8,49E-01 −1,26 4,01E-01 N.A N.D.
SERPINI1 1,29 3,55E-13 1,01 7,54E-01 N.A. N.D. −1,04 4,02E-01 −1,06 2,30E-01 −1,01 7,64E-01 −1,07 4,68E-02 N.A N.D.
TAU −1,02 5,66E-01 −1,02 4,84E-01 1,09 6,02E-01 1,15 1,48E-04 1,38 6,24E-01 1,16 2,85E-06 1,11 4,07E-04 1,08 5,07E-01
ACHE 1,02 6,09E-01 −1,10 5,86E-03 N.A. N.D. 1,18 2,15E-04 1,18 1,26E-04 1,30 1,63E-09 1,20 3,80E-06 N.A N.D.

Abbreviations: FC, Fold change; FDR-P, FDR corrected P-value